Received Sep 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
Diagnosed with Covid/First symptons were flu like and started mild; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with Covid/First symptons were flu like and started mild) in a 67-year-old male patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. Previously administered products included for COVID-19 prophylaxis: Moderna's Covid 19 vaccines (Patient received all Moderna's Covid-19 vaccines twice a year: Spring/Fall.). Past adverse reactions to the above products included No adverse effect with Moderna's Covid 19 vaccines. In September 2024, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) 1 dosage form. On 31-Dec-2024, the patient experienced COVID-19 (Diagnosed with Covid/First symptons were flu like and started mild). The patient was treated with Nirmatrelvir, Ritonavir (Paxlovid) from 01-Jan-2025 to January 2025 for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (Diagnosed with Covid/First symptons were flu like and started mild) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Dec-2024, SARS-CoV-2 test: Positive. Concomitant medication use information was not provided by reporter. The reporter wanted to know where to get it and what the difference was between mNEXSPIKE and Spikevax, and which would be more effective for a patient who got Covid despite having had the Moderna Covid vaccine in September 2024. Up until the patient tested positive on 31-Dec-2024 at 67 years old, one week after being on vacation at the museum. The reporter assumed that this was where the patient got Covid because, while the patient was at that museum, although everyone was wearing a mask, it was filled with hundreds of children running all over the place. The first symptoms were flu-like and started mild. The patient was never hospitalized. The symptoms just persisted. The reporter called his HCP as soon as the patient was diagnosed with Covid, and the patient agreed on starting a treatment because the traveling was involved, so the patient had a specific 5-day treatment with Paxlovid on January 1st. The last vaccine taken was Pfizer in April 2025. It was unknown if the patient experienced any additional symptoms/events. Reporter did not allow further contact
Test Date: 20241231; Test Name: COVID-19 Virus test; Test Result: Positive